61958-2901 : Remdesivir 100 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 61958-2901 |
Labeler: | Gilead Sciences, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Rev. Date: |
NDC Package Codes:
- 61958-2901-1: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (61958‑2901‑1) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑DOSE
- 61958-2901-2: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (61958‑2901‑2) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Remdesivir
Dosage Strength:
- 100 mg
Pharmaceutical Classes:
- SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 61958-2902 Remdesivir 5 mg/ml Intravenous Injection by Gilead Sciences, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 61958-2505Next: 61958-2902 >
Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.